Catalyst Wire Dossier Catalyst Wire Dossier

Varespladib

varespladib · Ophirex, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Varespladib, covering 2012-03-20 to 2025-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite [Phase 2]

See pricing